MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Alpha-synuclein fibril-based mouse model of REM sleep behavior disorder as a prodrome of synucleinopathy

    HS. Yoo, R. Luke, C. Durso, Y. Liang, J. Steltz, D. Chernoff, B. Zhang, KH. Hoxha, B. Dugan, JJ. Fraigne, W. O’Brien, J. Peever, K. Luk (Seoul, Republic of Korea)

    Objective: To investigate whether in wild-type mice, inoculation of α-synuclein (aSyn) preformed fibrils (PFFs) into the sublaterodorsal tegmental nucleus (SLD), a core structure associated with…
  • 2022 International Congress

    Visuospatial deficits characterize Pisa syndrome and not Camptocormia in Parkinson’s disease

    CA. Artusi, E. Montanaro, R. Erro, N. Margraf, C. Geroin, F. Spagnolo, A. Pilotto, L. Magistrelli, A. Marchet, M. Zibetti, C. Comi, A. Padovani, M. Tinazzi, L. Lopiano (Torino, Italy)

    Objective: We performed a multicenter, case-control study with the aim to analyze cognitive differences between parkinsonian patients with Pisa syndrome or camptocormia and matched controls…
  • 2022 International Congress

    Impact of the delayed diagnosis in the prognosis of Parkinson’s disease.

    E. Ichikawa-Escamilla, AJ. Hernández-Medrano, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, GI. Cerda-Hernández, MA. Ruíz-Mafud, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To evaluate the difference of motor and non-motor dysfunction, and quality of life in Parkinson’s disease (PD) patients with and without delayed diagnosis. Background:…
  • 2022 International Congress

    Structural MRI features of glucocerebrosidase (GBA)-associated Parkinson’s disease

    R. Patel, T. Stoub, B. Cozzi, G. Pal (Chicago, USA)

    Objective: To compare structural differences in brain magnetic resonance imaging (MRI) between Glucocerebrosidase (GBA) mutation carriers with Parkinson’s disease (PD-GBA) vs non-mutation carriers. Background: PD-GBA…
  • 2022 International Congress

    Cerebellar and other motor symptoms in Huntington’s Disease: A multiple scale correlation study

    D. López-Mena, H. Martinez-Hernandez, J. Arista-Ramírez (Ciudad de Mexico, Mexico)

    Objective: To describe the cerebellar symptoms and other accompanying movement disorders in Huntington's Disease (HD). Background: HD is a pathological entity whose etiological substrate is…
  • 2022 International Congress

    Multi-modal MRI features and their relationship with clinical scales in Parkinson disease and Atypical Parkinsonian Syndromes

    H. Martinez-Hernandez, D. Lopez-Mena, B. Candela-Solano, A. Medina-Islas, L. Alvarez, I. Acosta (Mexico City, Mexico)

    Objective: To compare MRI sings and volumetric measurements in Parkinson disease (PD), Progressive Supranuclear Palsy (PSP), and Multiple System Atrophy (MSA) and their relationship with…
  • 2022 International Congress

    DBS Experience In A Pediatric Neurowilson Case

    S. Bozkaya Yilmaz, N. Olgaç Dündar, G. Basarir, P. Gencpinar, A. Ersen (Izmir, Turkey)

    Objective: I have chosen this case to demonstrate an atypical presentation of Neuro-Wilson disease without a prominent hepatic involvement. I have also aimed to call…
  • 2022 International Congress

    Bullous skin lesions following introduction of safinamide in a woman with Parkinson’s disease

    L. Lachance, P. Huot (Montreal, Canada)

    Objective: To present the case of a woman with Parkinson’s disease (PD) who developed pemphigoid-like skin lesions after being started on safinamide therapy. Background: Safinamide…
  • 2022 International Congress

    Cognitive and Functional Trajectories in Prediagnostic Parkinson’s Disease

    M. Bock, E. Vittinghoff, A. Bahorik, Y. Leng, K. Yaffe (San Francisco, USA)

    Objective: To describe prediagnostic cognitive and functional trajectories in Parkinson’s Disease (PD). Background: Cognitive and functional decline is typically considered a late manifestation of PD.…
  • 2022 International Congress

    Blaming neuromelanin for Parkinson’s disease: time-dependent tyrosinase overexpression drives endogenous synucleinopathy in non-human primates

    J. Lanciego, J. Chocarro, A. Fajardo-Serrano, A. Vazquez, AI. Rodriguez-Perez, J. Labandeira-Garcia, M. Vila, A. Rico (Pamplona, Spain)

    Objective: Development and characterization of a novel non-human primate model of Parkinson’s disease based on the AAV-mediated forced expression of human tyrosinase Background: Although neuromelanin…
  • « Previous Page
  • 1
  • …
  • 132
  • 133
  • 134
  • 135
  • 136
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley